Showing results (21-30 of 147) with videos related to
Sort By:
Pageof 15
Diabetes|April 11, 2024
Efficient Vascular and Neural Engraftment of Stem Cell-Derived IsletsJulia Thorngren, Anja Brboric, Svitlana Vasylovska, et al.Stem Cell Research|June 22, 2015
Generation of iPSC line HEL24.3 from human neonatal foreskin fibroblastsRas Trokovic, Jere Weltner, Timo OtonkoskiStem Cell Research|June 23, 2015
Generation of iPSC line HEL47.2 from healthy human adult fibroblastsRas Trokovic, Jere Weltner, Timo OtonkoskiAnnals of Medicine|November 10, 2005
Stem cells in the treatment of diabetesTimo Otonkoski, Ru Gao, Karolina LundinDuodecim; Laaketieteellinen Aikakauskirja|May 15, 2014
[Induced pluripotent stem cells (iPS) in medical research]Jere Weltner, Ras Trokovic, Timo OtonkoskiElife|November 10, 2018
Insulin mutations impair beta-cell development in a patient-derived iPSC model of neonatal diabetesDiego Balboa, Jonna Saarimäki-Vire, Daniel Borshagovski, et al.Diabetes|October 23, 2024
IER3IP1 Mutations Cause Neonatal Diabetes Due to Impaired Proinsulin TraffickingHossam Montaser, Sonja Leppänen, Eliisa Vähäkangas, et al.Duodecim; Laaketieteellinen Aikakauskirja|January 7, 2015
[Human stem cells in the treatment of pancreatic and hepatic diseases]Elina Hakonen, Sanna Toivonen, Hannu Jalanko, et al.American Journal of Medical Genetics. Part A|April 1, 2004
A syndrome with multiple malformations, mental retardation, and ACTH deficiencyEero Kajantie, Timo Otonkoski, Sirpa Kivirikko, et al.Frontiers in Endocrinology|February 2, 2023
<i>In vitro</i> beta-cell killing models using immune cells and human pluripotent stem cell-derived islets: Challenges and opportunitiesClémentine Halliez, Hazem Ibrahim, Timo Otonkoski, et al.Pageof 15